Time-averaged hemoglobin values, not hemoglobin cycling, have an impact on outcomes in pediatric dialysis patients


BAKKALOĞLU EZGÜ S. A. , KANDUR Y., Serdaroglu E., Noyan A., KARABAY BAYAZIT A., Tasdemir M., et al.

PEDIATRIC NEPHROLOGY, cilt.33, ss.2143-2150, 2018 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 33 Konu: 11
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1007/s00467-018-4013-4
  • Dergi Adı: PEDIATRIC NEPHROLOGY
  • Sayfa Sayısı: ss.2143-2150

Özet

During erythropoietin-stimulating agent (ESA) treatment, hemoglobin (Hb) levels usually fluctuate; this phenomenon is known as "Hb cycling (HC)." In this study, we aimed to evaluate the predictors of HC and its impact on left ventricular hypertrophy (LVH) as a patient-important outcome parameter in pediatric dialysis patients.